1 documents found
Information × Registration Number 0216U000336, 0113U001201 , R & D reports Title To study the significance of HLA phenotypes in patients with proliferative and nonproliferative glomerulonephritis for effectiveness of treatment popup.stage_title Head Kolesnyk M.O., Registration Date 29-01-2016 Organization Institute of Nephrology Ukraine Academi Science of Medicine popup.description2 It is advisable to associate chronic GN, NS (RR > 2) with antigens HLA- A23, 24, 28; B8, 38, 41, 44 in patients; the causal role was determined for A24, 28; B8. In patients with proliferative GN was additionally revealed the etiologic role of B27, known as antigen associated with risk of autoimmune diseases. In patients with chronic GN is advisable the association of antigens- A30, B41 in patients with FSGS, A10 - in patients with primary Membranous Nephropathy with development chronic renal failure and also hormone resistance - A19+31+32 in patients with FSGS, B8 - in patients with primary Membranous Nephropathy and Minimal Changes Disease. Product Description popup.authors Алексєєва Н.Г. Бурдейна О.В. Величко М.Б. Гуріна Ю.В. Дріянська В.Є. Драннік Г.М. Епіфанов В.М. Капустяк А.І. Козлюк Н.І. Колесник М.О. Ліксунова Л.О. Непомнящий В.М. Петрина О.П. СавченкоС.М. Сидоренко Є.М. popup.nrat_date 2020-04-02 Close
R & D report
To study the significance of HLA phenotypes in patients with proliferative and nonproliferative glomerulonephritis for effectiveness of treatment
Head: Kolesnyk M.O.. To study the significance of HLA phenotypes in patients with proliferative and nonproliferative glomerulonephritis for effectiveness of treatment. (popup.stage: ). Institute of Nephrology Ukraine Academi Science of Medicine. № 0216U000336
1 documents found

Updated: 2026-03-21


Роздрукувати цю сторінку